GGrantIndex
← Leaderboards

Scott M Berry

University Of Wisconsin-Madison

$6,162,635
Attributed
$7,964,408
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY201422
$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$7,964,408 · 7

By mechanism

U01$3,380,557 · 1
R44$1,745,928 · 2
R01$1,552,947 · 1
R43$925,000 · 2
R21$359,976 · 1

Top collaborators

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseSamplingTechnologyUniversitiesPreparationProteinsWisconsinCellsExclusionDevicesResponseNucleic AcidsBloodProspectiveImageFutureSuccessBiological ModelsGoldInterestBiological MarkersAdvanced Malignant NeoplasmClinical TrialsMessenger Rna

Grant awards (16)

Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology$1,546,299
U01 · FY2022 · DA · contact PI
Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology$1,834,258
U01 · FY2021 · DA · contact PI
The Dual Reporter Sensor Cell (DRSC) Assay: An Enhanced Tool for Measuring the Viral Reservoir$187,306
R21 · FY2021 · AI · contact PI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$436,366
R44 · FY2020 · HD
The Dual Reporter Sensor Cell (DRSC) Assay: An Enhanced Tool for Measuring the Viral Reservoir$172,670
R21 · FY2020 · AI · contact PI
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$533,801
R44 · FY2018 · GM
Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
R43 · FY2018 · OD
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis$311,847
R01 · FY2018 · CA
Development of a cell based assay to assess antigen specific tolerance$225,000
R43 · FY2018 · AI
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$535,014
R44 · FY2017 · GM · contact PI
Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression$350,000
R43 · FY2017 · OD · contact PI
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis$311,847
R01 · FY2017 · CA
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis$311,847
R01 · FY2016 · CA
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples$240,747
R44 · FY2016 · GM · contact PI
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis$311,847
R01 · FY2015 · CA
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis$305,559
R01 · FY2014 · CA